These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17557353)

  • 1. An open trial of levetiracetam for segmental and generalized dystonia.
    Hering S; Wenning GK; Seppi K; Poewe W; Mueller J
    Mov Disord; 2007 Aug; 22(11):1649-51. PubMed ID: 17557353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam for the treatment of generalized dystonia.
    Sullivan KL; Hauser RA; Louis ED; Chari G; Zesiewicz TA
    Parkinsonism Relat Disord; 2005 Nov; 11(7):469-71. PubMed ID: 16014339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label trial of levetiracetam for treatment of cervical dystonia.
    Tarsy D; Ryan RK; Ro SI
    Mov Disord; 2006 May; 21(5):734-5. PubMed ID: 16570301
    [No Abstract]   [Full Text] [Related]  

  • 5. Levetiracetam in the treatment of idiopathic generalized epilepsies.
    Grünewald R
    Epilepsia; 2005; 46 Suppl 9():154-60. PubMed ID: 16302890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia.
    Löscher W; Richter A
    Eur J Pharmacol; 2000 Mar; 391(3):251-4. PubMed ID: 10729365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substantial improvement in a Meige's syndrome patient with levetiracetam treatment.
    Zesiewicz TA; Louis ED; Sullivan KL; Menkin M; Dunne PB; Hauser RA
    Mov Disord; 2004 Dec; 19(12):1518-21. PubMed ID: 15390069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with levetiracetam in idiopathic generalized epilepsy according to different syndrome subtypes.
    Di Bonaventura C; Fattouch J; Mari F; Egeo G; Vaudano AE; Prencipe M; Manfredi M; Giallonardo AT
    Epileptic Disord; 2005 Sep; 7(3):231-5. PubMed ID: 16162433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study.
    Striano P; Manganelli F; Boccella P; Perretti A; Striano S
    Mov Disord; 2005 Dec; 20(12):1610-4. PubMed ID: 16078205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam prophylaxis in pediatric migraine--an open-label study.
    Pakalnis A; Kring D; Meier L
    Headache; 2007 Mar; 47(3):427-30. PubMed ID: 17371359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
    Specchio N; Boero G; Michelucci R; Gambardella A; Giallonardo AT; Fattouch J; Di Bonaventura C; de Palo A; Ladogana M; Lamberti P; Vigevano F; La Neve A; Specchio LM
    Epilepsia; 2008 Apr; 49(4):663-9. PubMed ID: 18266754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited efficacy of levetiracetam on myoclonus of different etiologies.
    Lim LL; Ahmed A
    Parkinsonism Relat Disord; 2005 Mar; 11(2):135-7. PubMed ID: 15734675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy.
    Bailey KS; Dewey CW; Boothe DM; Barone G; Kortz GD
    J Am Vet Med Assoc; 2008 Mar; 232(6):867-72. PubMed ID: 18341442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
    Xiao Z; Li JM; Wang XF; Xiao F; Xi ZQ; Lv Y; Sun HB
    Eur Neurol; 2009; 61(4):233-9. PubMed ID: 19176965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of levetiracetam in hemifacial spasm: a case report.
    Biagio Carrieri P; Petracca M; Montella S
    Clin Neuropharmacol; 2008; 31(3):187-8. PubMed ID: 18520988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study.
    Brighina F; Palermo A; Aloisio A; Francolini M; Giglia G; Fierro B
    Clin Neuropharmacol; 2006; 29(6):338-42. PubMed ID: 17095897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam is not effective for essential tremor.
    Elble RJ; Lyons KE; Pahwa R
    Clin Neuropharmacol; 2007; 30(6):350-6. PubMed ID: 18090460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study.
    López-Góngora M; Martínez-Domeño A; García C; Escartín A
    Epileptic Disord; 2008 Dec; 10(4):297-305. PubMed ID: 19017572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.